Targeting Exciting Inflammasome Field, NodThera Raises $55m

Among Pioneers Of NLRP3 Inhibitors

 
• By Andrew McConaghie
  
Research_Lab
Research into NLRP3 inhibitors has gained momentum in the last few years
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip